Moderna halts development of birth defect vaccine after trial setback – Reuters
		
		
		
- Moderna halts development of birth defect vaccine after trial setback  Reuters
- Moderna says key study of its CMV vaccine, expected to be its next big win, failed  statnews.com
- Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint  Yahoo Finance
- Moderna Drops Vaccine for Birth Defects After Trial Failure  Barron’s
- Moderna Vaccine Fails to Prevent Infection Tied to Birth Defects  Bloomberg.com